Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Neonatology

Long-Term Outlook: Brain Development and Life After the NICU

At a Glance

Routine, brief apnea events in the NICU do not cause permanent brain damage. Apnea of prematurity naturally resolves on its own by a baby's original due date as the brainstem matures, and it does not increase the child's long-term risk of asthma or SIDS.

It is perhaps the most frightening question a parent can ask: “Will these oxygen drops hurt my baby’s brain?” When you watch the numbers on the monitor dip into the red, it is natural to fear that every “spell” is causing permanent damage. However, decades of research provide a much more hopeful perspective on how premature babies recover and thrive after Apnea of Prematurity [1][2].

The Reality of Intermittent Hypoxia

The medical term for temporary drops in oxygen is intermittent hypoxia (IH) [3]. To be incredibly clear: routine, brief apnea events (“As and Bs”) in the NICU that a baby quickly recovers from do NOT cause permanent brain damage.

While it is true that severe, prolonged lack of oxygen can damage sensitive brain areas like the cerebellum, the brief, daily “spells” your baby is having are fundamentally different [4]. The NICU’s continuous monitoring, alarms, and interventions (like caffeine and CPAP) exist entirely to prevent these brief drops from ever becoming prolonged [5][6]. Your baby’s developing brain is incredibly resilient, and it is protected by the care team’s rapid responses.

Caffeine: A Long-Term Success Story

One of the most reassuring pieces of data for NICU parents comes from the CAP (Caffeine for Apnea of Prematurity) Trial. This landmark study followed thousands of preemies into childhood to see how caffeine therapy affected them years later.

  • Motor Skills: Children who received caffeine in the NICU actually had a lower risk of motor impairment at age 11 compared to those who did not [7].
  • Cognitive and Behavioral Health: The studies found no adverse effects on general intelligence, attention, behavior, or “executive function” (the brain’s ability to plan and manage tasks) [1][2].
  • Safe and Effective: Overall, caffeine is considered one of the safest and most effective “neuroprotective” medicines used in the NICU, meaning it actively helps protect the brain while it matures [8][9].

When Does AOP Finally Stop?

Apnea of Prematurity is a “self-limiting” condition, meaning it goes away on its own as the baby grows [10].

  • The 40-Week Milestone: For most infants, AOP naturally resolves as they reach term equivalence (between 36 and 40 weeks of corrected age) [10][11].
  • Brainstem Maturation: This resolution happens because the brainstem—the control center for breathing—completes the complex wiring needed to keep breathing steady, even during deep sleep [10].
  • Individual Timelines: While most babies are stable by their due date, some very tiny infants (those born before 28 weeks) may continue to have occasional, mild events for a few weeks longer [11][12].

Life After the NICU

Once your baby’s respiratory system has matured and they have cleared their “apnea-free” countdown, the risk of AOP returning is extremely low [13]. Parents often worry if AOP leads to other issues like asthma or SIDS later in life, but research generally shows that AOP is a separate, developmental issue related to prematurity that does not dictate a child’s long-term respiratory health [10][14].

In fact, children who were treated with caffeine often show improved respiratory health in mid-childhood, with better lung function tests than those who did not receive the treatment [14][6]. Your baby isn’t just surviving these events; they are growing through them, supported by a medical plan that prioritizes their long-term potential.

Common questions in this guide

Will brief oxygen drops from AOP cause permanent brain damage to my baby?
Routine, brief apnea events that a baby quickly recovers from do not cause permanent brain damage. The continuous NICU monitoring and quick interventions by your care team ensure these brief drops do not become prolonged.
Does caffeine therapy in the NICU affect my baby's long-term development?
Caffeine is considered a very safe neuroprotective medicine that actively helps protect your baby's developing brain. Research shows that preemies treated with caffeine actually have a lower risk of motor impairment and no adverse cognitive effects as they grow.
When will my baby's apnea of prematurity finally stop?
For most infants, apnea of prematurity goes away naturally by their original due date, usually between 36 and 40 weeks. This happens because the brainstem completes the necessary wiring to keep breathing steady, even during deep sleep.
Does having AOP increase my child's risk of asthma or SIDS later in life?
No, apnea of prematurity is a developmental issue related to being born early and does not dictate a child's long-term respiratory health. Research shows that surviving AOP does not increase the risk of developing asthma or SIDS later in life.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my baby's specific history of apnea, are there any specialized neurodevelopmental follow-ups you recommend after we go home?
  2. 2.Does my baby's cerebellar development look normal on their scans, given that this area is sensitive to oxygen drops?
  3. 3.How do you weigh the benefits of caffeine against the frequency of the desaturations my baby is still having?
  4. 4.Are there specific milestones I should look for in the first six months that will tell me their breathing drive is fully mature?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Neurobehavioral Outcomes 11 Years After Neonatal Caffeine Therapy for Apnea of Prematurity.

    Mürner-Lavanchy IM, Doyle LW, Schmidt B, et al.

    Pediatrics 2018; (141(5)) doi:10.1542/peds.2017-4047.

    PMID: 29643070
  2. 2

    Five-year outcomes of premature infants randomized to high or standard loading dose caffeine.

    McPherson C, Lean RE, Cyr PEP, et al.

    Journal of perinatology : official journal of the California Perinatal Association 2022; (42(5)):631-635 doi:10.1038/s41372-022-01333-5.

    PMID: 35145209
  3. 3

    Intermittent Hypoxia in Preterm Neonates and Its Effect on Neonatal Morbidity and Mortality: A Systematic Review.

    Mandala VK, Bollaboina SKY, Changala B, et al.

    Cureus 2023; (15(9)):e45561 doi:10.7759/cureus.45561.

    PMID: 37868466
  4. 4

    Apnea of prematurity induces short and long-term development-related transcriptional changes in the murine cerebellum.

    Rodriguez-Duboc A, Basille-Dugay M, Debonne A, et al.

    Current research in neurobiology 2023; (5()):100113 doi:10.1016/j.crneur.2023.100113.

    PMID: 38020806
  5. 5

    Apnea of Prematurity and Oxidative Stress: Potential Implications.

    Thompson L, Werthammer JW, Gozal D

    Antioxidants (Basel, Switzerland) 2024; (13(11)) doi:10.3390/antiox13111304.

    PMID: 39594446
  6. 6

    Methylxanthines: The Major Impact of Caffeine in Clinical Practice in Patients Diagnosed with Apnea of Prematurity.

    Neamțu AV, Zlatian OM, Manda CV, et al.

    Journal of clinical medicine 2025; (14(23)) doi:10.3390/jcm14238417.

    PMID: 41375719
  7. 7

    Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.

    Schmidt B, Roberts RS, Anderson PJ, et al.

    JAMA pediatrics 2017; (171(6)):564-572 doi:10.1001/jamapediatrics.2017.0238.

    PMID: 28437520
  8. 8

    Methylxanthine for the prevention and treatment of apnea in preterm infants.

    Marques KA, Bruschettini M, Roehr CC, et al.

    The Cochrane database of systematic reviews 2023; (10()):CD013830 doi:10.1002/14651858.CD013830.pub2.

    PMID: 37905735
  9. 9

    The utility of caffeine citrate as a neuroprotectant in the early life of premature newborns: a literature review of the effects on neurodevelopmental outcomes.

    Phung L, Duong K, Obeid R

    Frontiers in pediatrics 2025; (13()):1682903 doi:10.3389/fped.2025.1682903.

    PMID: 41488901
  10. 10

    Treating Apnea of Prematurity.

    Pergolizzi J, Kraus A, Magnusson P, et al.

    Cureus 2022; (14(1)):e21783 doi:10.7759/cureus.21783.

    PMID: 35251853
  11. 11

    Achievement of maturational milestones among very low birth weight infants.

    Sullivan BA, Slevin CC, Ahmad SM, et al.

    Journal of neonatal-perinatal medicine 2022; (15(1)):155-163 doi:10.3233/NPM-200698.

    PMID: 33967061
  12. 12

    Caffeine therapy for apnoea of prematurity: Wake up to the fact that sex matters.

    McDonald FB, Dempsey EM, O'Halloran KD

    Experimental physiology 2018; (103(10)):1294-1295 doi:10.1113/EP087222.

    PMID: 30070403
  13. 13

    Recurrence of apnea of prematurity following early discontinuation of caffeine: A prospective analytical study.

    Kumar N, Rahul A, Nandakumar A, et al.

    Journal of neonatal-perinatal medicine 2026; (19(2)):215-221 doi:10.1177/19345798251380137.

    PMID: 40987473
  14. 14

    Neonatal Caffeine Treatment and Respiratory Function at 11 Years in Children under 1,251 g at Birth.

    Doyle LW, Ranganathan S, Cheong JLY

    American journal of respiratory and critical care medicine 2017; (196(10)):1318-1324 doi:10.1164/rccm.201704-0767OC.

    PMID: 28707987

This page explains the long-term outlook of apnea of prematurity for educational purposes. Always consult your neonatologist or pediatrician regarding your baby's specific neurodevelopmental progress.

Get notified when new evidence is published on Apnea of prematurity.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.